These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27743738)

  • 1. Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis.
    Fader AN; Java J; Tenney M; Ricci S; Gunderson CC; Temkin SM; Spirtos N; Kushnir CL; Pearl ML; Zivanovic O; Tewari KS; O'Malley D; Hartenbach EM; Hamilton CA; Gould NS; Mannel RS; Rodgers W; Walker JL
    Gynecol Oncol; 2016 Dec; 143(3):460-465. PubMed ID: 27743738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study.
    Seagle BL; Dayno M; Strohl AE; Graves S; Nieves-Neira W; Shahabi S
    Gynecol Oncol; 2016 Dec; 143(3):472-478. PubMed ID: 27760707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Survival Outcomes of Uterine Papillary Serous Carcinoma, Clear Cell Carcinoma, Grade 3 Endometrioid Adenocarcinoma, and Carcinosarcoma of Endometrial Cancer in Rajavithi Hospital.
    Prueksaritanond N; Chantape W
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S75-83. PubMed ID: 27266220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of lymph node dissection and overall survival in patients with uterine carcinosarcoma, papillary serous and endometrioid adenocarcinoma: A retrospective cohort study.
    Alagkiozidis I; Weedon J; Grossman A; Wang P; Mize B; Wilson K; Shah T; Economos K; Salame G; Abulafia O; Lee YC
    Int J Surg; 2015 Dec; 24(Pt A):9-13. PubMed ID: 26476418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis.
    Bregar AJ; Alejandro Rauh-Hain J; Spencer R; Clemmer JT; Schorge JO; Rice LW; Del Carmen MG
    Gynecol Oncol; 2017 Apr; 145(1):114-121. PubMed ID: 28159409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a survival advantage in diagnosing endometrial cancer in asymptomatic postmenopausal patients? An Israeli Gynecology Oncology Group study.
    Gemer O; Segev Y; Helpman L; Hag-Yahia N; Eitan R; Raban O; Vaknin Z; Leytes S; Ben Arie A; Amit A; Levy T; Namazov A; Volodarsky M; Ben Shachar I; Atlas I; Bruchim I; Lavie O
    Am J Obstet Gynecol; 2018 Aug; 219(2):181.e1-181.e6. PubMed ID: 29792852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic staging for apparent stage I epithelial ovarian cancer.
    Melamed A; Keating NL; Clemmer JT; Bregar AJ; Wright JD; Boruta DM; Schorge JO; Del Carmen MG; Rauh-Hain JA
    Am J Obstet Gynecol; 2017 Jan; 216(1):50.e1-50.e12. PubMed ID: 27567562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoption of minimally invasive surgery after neoadjuvant chemotherapy in women with metastatic uterine cancer.
    Zhou ZN; Chen L; Melamed A; St Clair CM; Hou JY; Khoury-Collado F; Gockley A; Hershman DL; Wright JD
    Gynecol Oncol; 2022 Feb; 164(2):341-347. PubMed ID: 34920885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers.
    Altman AD; Ferguson SE; Atenafu EG; Köbel M; McAlpine JN; Panzarella T; Lau S; Gien LT; Gilks B; Clarke B; Cameron A; Nelson G; Han G; Samouëlian V; Ho TC; Louie K; Bernardini MQ
    Gynecol Oncol; 2015 Nov; 139(2):268-74. PubMed ID: 26352641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
    Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
    Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of minimally invasive surgery with laparotomic approach in the treatment of high risk endometrial cancer: A systematic review.
    Scaletta G; Dinoi G; Capozzi V; Cianci S; Pelligra S; Ergasti R; Fagotti A; Scambia G; Fanfani F
    Eur J Surg Oncol; 2020 May; 46(5):782-788. PubMed ID: 31818527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy.
    Matsuo K; Machida H; Takiuchi T; Garcia-Sayre J; Yessaian AA; Roman LD
    Gynecol Oncol; 2017 Apr; 145(1):41-49. PubMed ID: 28215841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas.
    Ayeni TA; Bakkum-Gamez JN; Mariani A; McGree ME; Weaver AL; Haddock MG; Keeney GL; Long HJ; Dowdy SC; Podratz KC
    Gynecol Oncol; 2013 Jun; 129(3):478-85. PubMed ID: 23535279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers.
    Bergstrom J; Aloisi A; Armbruster S; Yen TT; Casarin J; Leitao MM; Tanner EJ; Matsuno R; Machado KK; Dowdy SC; Soliman PT; Wethington SL; Stone RL; Levinson KL; Fader AN
    Gynecol Oncol; 2018 Mar; 148(3):480-484. PubMed ID: 29338923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic Versus Laparotomic Surgical Staging for Early-Stage Ovarian Cancer: A Case-Control Study.
    Gallotta V; Petrillo M; Conte C; Vizzielli G; Fagotti A; Ferrandina G; Fanfani F; Costantini B; Carbone V; Scambia G
    J Minim Invasive Gynecol; 2016; 23(5):769-74. PubMed ID: 26995493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective validation of an intraoperative algorithm to guide surgical staging in early endometrial cancer.
    Lefringhouse JR; Elder JW; Baldwin LA; Miller RW; DeSimone CP; van Nagell JR; Samoyoa LM; West DS; Dressler EV; Liu M; Ueland FR
    Gynecol Oncol; 2017 Apr; 145(1):50-54. PubMed ID: 28190648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma.
    Xu MJ; Chu C; Rubin S; Lin LL
    Am J Clin Oncol; 2017 Dec; 40(6):598-604. PubMed ID: 26237194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic features of surgical stage I uterine carcinosarcoma.
    Ferguson SE; Tornos C; Hummer A; Barakat RR; Soslow RA
    Am J Surg Pathol; 2007 Nov; 31(11):1653-61. PubMed ID: 18059221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer.
    Rauh-Hain JA; Hariton E; Clemmer J; Clark RM; Hall T; Boruta DM; Schorge JO; Del Carmen MG
    Obstet Gynecol; 2015 Jun; 125(6):1362-1370. PubMed ID: 26000507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.